Fund shareholders of Alvotech SA
ISIN LU2458332611 · Iceland · LEI 222100DCZBOWV5DZ8372
- Fund shareholders
- 25
- Of which ETFs
- 10 15 other funds
- Value held
- 30.2M $
- Sold short
- 0.6 % by 1 fund, as of Aug 20, 2026
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 1,671,323 | 6.5M $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 1,610,386 | 6.2M $ | 0.00 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price International Discovery Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 1,120,386 | 4.6M $ | 0.07 % | as of Jul 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 838,980 | 3.1M $ | 0.03 % | as of Jun 30, 2026 ↗ |
| Global Macro Absolute Return Advantage Portfolio Global Macro Absolute Return Advantage Portfolio | 593,154 | 2.3M $ | 0.03 % | as of Jul 31, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 523,957 | 1.9M $ | 0.81 % | as of Jun 30, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 257,257 | 993.5K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 244,900 | 1M $ | 0.53 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 200,581 | 674K $ | 0.00 % | as of May 31, 2026 ↗ |
| Global Macro Portfolio Global Macro Portfolio | 159,503 | 616K $ | 0.01 % | as of Jul 31, 2026 ↗ |
| Schwab Emerging Markets Equity ETF SCHWAB STRATEGIC TRUST | 133,299 | 460K $ | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 131,339 | 441.3K $ | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 124,610 | 481.2K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 73,335 | 302.1K $ | 0.01 % | as of Jul 31, 2026 ↗ |
| Parametric Emerging Markets Fund Eaton Vance Mutual Funds Trust | 66,700 | 274.8K $ | 0.13 % | as of Jul 31, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 22,471 | 77.2K $ | 0.00 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 17,707 | 59.5K $ | 0.09 % | as of May 31, 2026 ↗ |
| GlacierShares Nasdaq Iceland ETF Listed Funds Trust | 17,271 | 63.7K $ | 4.56 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 12,210 | 41K $ | 0.06 % | as of May 31, 2026 ↗ |
| Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II | 9,000 | 33.2K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 5,090 | 18.8K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Global Allocation Fund T. ROWE PRICE GLOBAL ALLOCATION FUND, INC. | 4,454 | 18.4K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS EX-CHINA ETF VANGUARD WORLD FUND | 3,275 | 11.2K $ | 0.00 % | as of May 31, 2026 ↗ |
| T. Rowe Price International Equity Research ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,613 | 6.6K $ | 0.02 % | as of Jul 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 670 | 2.8K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| GlacierShares Nasdaq Iceland ETF Listed Funds Trust | 4.56 % | as of Jun 30, 2026 ↗ |
| Royce Smaller-Companies Growth Fund ROYCE FUND | 0.81 % | as of Jun 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.53 % | as of Jul 31, 2026 ↗ |
| Parametric Emerging Markets Fund Eaton Vance Mutual Funds Trust | 0.13 % | as of Jul 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.09 % | as of May 31, 2026 ↗ |
| T. Rowe Price International Discovery Fund T. ROWE PRICE INTERNATIONAL FUNDS, INC. | 0.07 % | as of Jul 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.06 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.03 % | as of Jun 30, 2026 ↗ |
| Global Macro Absolute Return Advantage Portfolio Global Macro Absolute Return Advantage Portfolio | 0.03 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price International Equity Research ETF T. Rowe Price Exchange-Traded Funds, Inc. | 0.02 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 25 | +2 | 7,843,471 | +14.5 % |
| 2026Q2 | 23 | +1 | 6,851,751 | +1.3 % |
| 2026Q1 | 22 | -2 | 6,767,159 | -7.9 % |
| 2025Q4 | 24 | +1 | 7,349,161 | -0.2 % |
| 2025Q3 | 23 | -1 | 7,366,365 | +8.1 % |
| 2025Q2 | 24 | +8 | 6,815,249 | +57.1 % |
| 2025Q1 | 16 | +1 | 4,338,464 | +29.5 % |
| 2024Q4 | 15 | +2 | 3,349,016 | +17.5 % |
| 2024Q3 | 13 | +2 | 2,849,511 | +6.5 % |
| 2024Q2 | 11 | +7 | 2,675,340 | +1,708.5 % |
| 2024Q1 | 4 | -2 | 147,929 | -93.8 % |
| 2023Q4 | 6 | 2,399,793 |
Short sellers of Alvotech SA
Regulators publish the open short positions in this company. Titelia read them from quivad on Aug 20, 2026: today's figure
| Seller | Position | Disclosed on |
|---|---|---|
| Acasta Partners UK LLP | 0.6 % | Jun 17, 2026 |
Cite this page
Titelia. "Fund shareholders of Alvotech SA". https://titelia.com/en/stocks/alvotech-sa-LU2458332611